Phase II dose escalation study of caspofungin for invasive Aspergillosis.
Cornely OA, Vehreschild JJ, Vehreschild MJ, Würthwein G, Arenz D, Schwartz S, Heussel CP, Silling G, Mahne M, Franklin J, Harnischmacher U, Wilkens A, Farowski F, Karthaus M, Lehrnbecher T, Ullmann AJ, Hallek M, Groll AH.
Cornely OA, et al. Among authors: heussel cp.
Antimicrob Agents Chemother. 2011 Dec;55(12):5798-803. doi: 10.1128/AAC.05134-11. Epub 2011 Sep 12.
Antimicrob Agents Chemother. 2011.
PMID: 21911573
Free PMC article.
Clinical Trial.